This inventor holds 1 USPTO granted patent. Top assignee: London Health Sciences Centre Research Inc.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: The Innovative Contributions of Choi-Fong Cho
Introduction
Choi-Fong Cho is a prominent inventor based in Guelph, Canada. She has made significant strides in the field of biotechnology, particularly in the development of polypeptides that target and inhibit angiogenesis. Her work is crucial in addressing diseases that involve pathological angiogenesis, such as cancer.
Latest Patents
Choi-Fong Cho holds a patent for "EGFL7 targeting and/or binding polypeptides and methods for inhibiting angiogenesis." This patent describes polypeptides that target and bind to EGFL7 or its receptor, effectively reducing the pro-angiogenic activity of EGFL7. This innovation has potential applications in treating various diseases, disorders, or conditions associated with abnormal blood vessel growth.
Career Highlights
Choi-Fong Cho is affiliated with the London Health Sciences Centre Research Inc., where she continues to advance her research and contribute to the scientific community. Her dedication to innovation in biotechnology has positioned her as a key figure in her field.
Collaborations
Choi-Fong Cho has collaborated with notable colleagues, including John Lewis and Leonard Luyt. These partnerships have enhanced her research efforts and broadened the impact of her work.
Conclusion
Choi-Fong Cho's contributions to the field of biotechnology, particularly through her patent on EGFL7 targeting polypeptides, highlight her role as an influential inventor. Her work not only advances scientific knowledge but also holds promise for future medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile